Article
Luteal phase stimulation in double ovarian stimulation cycles is not affected by the follicle-stimulating hormone (FSH) receptor genotype: double ovarian stimulation is beneficial independently of the genotype at position 680 of the follicle-stimulating hormone receptor.
Pharmacogenetics and genomics - 1 Jan 2024
Hortal Mónica, Lledo Belén, Ortiz Jose A, Fuentes Ana, García-Ajofrín Cristina, Romero Ruth, Cascales Alba, Bernabeu Andrea, Bernabeu Rafael
Abstract excerpt
OBJECTIVES: To determine whether follicle-stimulating hormone receptor (FSHR) genotype influences the outcome of ovarian stimulation treatment in luteal phase. METHODS: A total of 299 patients were included in a retrospective study between July 2017 and December 2021. These patients carried out a double stimulation protocol and the variant Asn680Ser (rs6166; c.2039A>G) of FSH receptor was genotyped either as part...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.